Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells

Circulation

Volumn 98, Issue 12, 1998, Pages 1164-1171

  Gawaz, Meinrad ^a   Neumann, Franz Josef ^b   Dickfeld, Timm ^b   Koch, Werner ^b   Laugwitz, Karl Ludwig ^b   Adelsberger, Helmut ^b   Langenbrink, Kirsten ^b   Page, Sharon ^b   Neumeier, Dieter ^b   Schömig, Albert ^b   Brand, Korbinian ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Cell adhesion molecules; Endothelium; Genes; Platelets; Proteins

Indexed keywords

ADENOSINE DIPHOSPHATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; OLIGONUCLEOTIDE;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; THROMBOCYTE;

EID: 0032558466     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.12.1164     Document Type: Article

References (50)

1. Van Ijzendoorn SCD, Heemskerk JWM, Reutlingsperger CPM. Interactions between endothelial cells and blood platelets. Endothelium. 1995; 3:81-98.
2. Gimbrone MA Jr. Vascular endothelium: nature's blood container. In: Gimbrone MA Jr, ed. Vascular Endothelium in Hemostasis and Thrombosis. Edinburgh, UK: Churchill Livingstone; 1986:1-21.
3. Hawiger J. Platelet-vessel wall interactions. Atheroscler Rev. 1990;21: 165-186.
4. Benzakour A, Kanthou C. Cellular and molecular events in atherogenesis: basis for pharmacological and gene therapy approaches to restenosis. Cell Pharmacol. 1996;3:7-22.
5. Davies MJ. The contribution of thrombosis to the clinical expression of coronary atherosclerosis. Thromb Res. 1996;82:1-32.
6. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
7. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimuti T, Leonard E, Witztum JL, Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A. 1991;80:5252-5256.
8. Valente AJ, Rozek MM, Sprague EA, Schwartz CJ. Mechanisms of intimal monocyte-macrophage recruitment: special role for monocyte chemotactic protein-1. Circulation. 1992;86(suppl III):III-20-III-25.
9. Libby P, Sukhova G, Lee RT, Galis ZS. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol. 1995;25:59-S12.
10. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev. 1990;70:427-451.
11. Makgoba MW, Sanders ME, Ginther Luce GE, Dustin ML, Springer TA, Clark EA, Mannoni P, Shaw S. ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells. Nature. 1988;331:86-88.
12. Stauton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of intercellular adhesion molecule 1 (ICAM-1) demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988;52:925-933.
13. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 1991;65:859-873.
14. Heyward SA, Dubois-Stringfellow N, Rapoport R, Bautch VL. Expression and inducibility of vascular adhesion receptors in development. FASEB J. 1995;9:956-962.
15. Wertheimer SJ, Myers CL, Wallace RW, Parks TP. Intercellular adhesion molecule-1 gene expression in human endothelial cells. J Biol Chem. 1992;267:12030-12035.
16. Collins T. Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest. 1993;68:499-508.
17. Baeuerle PA. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim Biophys Acta. 1991;1072:63-80.
18. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 1995;9:899-909.
19. Brand K, Page S, Rogler G, Bartsch A, Brandi R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest. 1996;97:1715-1722.
20. Brand K, Page S, Walli AK, Neumeier D, Baeuerle PA. Role of NF-kappa B in atherogenesis. Exp Physiol. 1997;82:297-304.
21. Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, Morrissey JH, Prescott SM, Zimmerman GA. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest. 1996;97: 1525-1534.
22. Neumann FJ, Marx N, Gawaz M, Brand K, Ott I, Rokitta C, Sticherling C, Meindl C, May A, Schömig A. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation. 1997;95:2387-2394.
23. Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, Fukushima J, Kawamoto S, Ishigatsubo Y, Okubo T. NF-κB and Sp 1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol. 1994;143:2052-2063.
24. Jaffe EA, Nachman RL, Becker CG, Minich CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest. 1973;52: 2745-2752.
25. Gawaz M, Neumann FJ, Ott I, Schiessler A, Schömig A. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation. 1996;93:229-237.
26. Gawaz M, Dickfeld T, Bogner C, Fateh-Moghadam S, Neumann FJ. Platelet function in septic multiple organ dysfunction syndrome. Int Care Med. 1997;23:379-385.
27. Gawaz M, Ott I, Reininger A, Heinzmann U, Neumann FJ. Agglutination of isolated platelet membranes. Atheroscler Thromb Vasc Biol. 1996;16: 621-627.
28. 3,) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation. 1997;96: 1809-1818.
29. Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor κB binding sites. J Exp Med. 1991;174:1517-1526.
30. Bielinska A, Shivdasani RA, Zhang L, Nabel GJ. Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science. 1990;250:997-1000.
31. Ech SL, Perkins ND, Carr DP, Nabel GJ. Inhibition of phorbol ester-induced cellular adhesion by competitive binding of NF-κB in vivo. Mol Cell Biol. 1993;13:6530-6536.
32. Willerson JT, Golino P, Eidt J, Campbell WB, Buja LM. Specific platelet mediators and unstable coronary artery lesions: experimental evidence and potential clinical implications. Circulation. 1989;80:198-205.
33. Hirsh PD, Hillis LD, Campbell WB, Firth BG, Willerson JT. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. N Engl J Med. 1981;304:685-691.
34. Golino P, Ashton JH, Buja LM, Taylor AL, McNatt J, Rosolowsky M, Campbell WB, Willerson JT. Local platelet activation causes vasocon-striction of large epicardial canine coronary arteries in vivo: thromboxane A2 and serotonin are possible mediators. Circulation. 1989;79:154-166.
35. Siess W. Molecular mechanisms of platelet activation. Physiol Rev. 1989; 69:58-178.
36. Walsh PN, Schmaier AH. Platelet-coagulant protein interactions. In: Colman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 3rd ed. Philadelphia, Pa: JB Lippincott Co; 1994;629-651.
37. Gershlick AH. Principles of platelet inhibitor therapy: where we stood in 1993. Eur Heart J. 1994;15:149-155.
38. Thanos D, Maniatis T. NF-κB: a lesson in family values. Cell. 1995;80: 529-532.
39. Defillipi P, Silengo L, Tarone G. Regulation of adhesion receptor expression in endothelial cells. Curr Top Microbiol Immunol. 1993;184: 87-98.
40. Beltinger C, Saragovi HU, Smith RM, LeSauteur L, Shah N, DeDionisio L, Christensen L, Raible A, Jarett L, Gerwitz AM. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin Invest. 1995;95:1814-1823.
41. Mahato RI, Takakura Y, Hashida M. Nonviral vectors for in vivo gene delivery: physicochemical and pharmacokinetic considerations. Crit Rev Ther Drug Carrier Syst. 1997;14:133-172.
42. Hawrylowicz CM, Santoro SA, Platt FM, Unanue ER. Activated platelets express IL-1 activity. J Immunol. 1989;143:4015-4018.
43. Tedgui A, Bernard C. Cytokines, immuno-inflammatory response and atherosclerosis. Eur Cytokine Netw. 1994;5:263-270.
44. Kawaguchi H, Shin WS, Wang YP, Inukai M, Kato M, Matsuo-okai Y, Sakamoto A, Uehara Y, Kaneda Y, Toyo-oka T. In vivo gene transfection of human endothelial cell nitric oxide synthetase in cardiomyocytes causes apoptosis-like cell death: identification using Sendai virus-coated liposomes. Circulation. 1997;95:2441-2447.
45. Packham MA, Mustard JF. The role of platelets in the development and complications of atherosclerosis. Semin Hematol. 1986;23:8-26.
46. Feldman LJ, Tahlil O, Steg G. Perspectives of arterial gene therapy for the prevention of restenosis. Cardiovasc Res. 1996;32:194-207.
47. Lindner V, Collins T. Expression of NF-kappa B and I kappa B-alpha by aortic endothelium in an arterial injury model. Am J Pathol. 1996;148: 427-438.
48. Cercek B, Yamashita M, Dimayuga P, Zhu J, Fishbein MC, Kaul S, Shah PK, Nilsson J, Regnstrom J. Nuclear factor-κB activity and arterial response to balloon injury. Atherosclerosis. 1997;131:59-66.
49. Jang Y, Lincoff AM, Plow EF, Topol EJ. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol. 1994;24:1591-1601.
50. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, Ogihara T. In vivo transfection of cis element decoy against nuclear factor-KB binding sites prevents myocardial infarction. Nat Med. 1997;3:894-899.